Oncology PracticeSkin cancer a concern in pediatric solid organ transplant recipientsDecember 7, 2016PediatricsPatient & Survivor CareTransplantPreventive CareNonmelanoma Skin CancerMelanoma
Oncology PracticeSex differences in T-cell profiles may drive anti–PD-L1 responsesNovember 20, 2016Melanoma
Oncology PracticeNivolumab + ipilimumab induced fulminant, fatal myocarditisNovember 2, 2016MelanomaImmuno-oncology
Oncology PracticeCancer survivors report two times greater medication use for anxiety and depressionOctober 26, 2016Patient & Survivor CareMelanomaGynecologic CancerBreast CancerGastroenterologyGenitourinary CancerMixed Topics
Oncology PracticePD-L1 positivity correlated with pembrolizumab response in advanced melanomaOctober 13, 2016Melanoma
Oncology PracticeSurvival benefit maintained long term with ipilimumab for high-risk melanomaOctober 12, 2016Melanoma
Oncology PracticeFDA modifies dosage regimen for nivolumabSeptember 19, 2016Lung CancerGenitourinary CancerLymphoma & Plasma Cell DisordersMelanomaRenal Cell Carcinoma
Oncology PracticeStudy suggests link between commonly used antihypertensive drug and skin cancerSeptember 17, 2016Melanoma
